New device could free AF patients from lifelong blood thinners
NCT ID NCT06049615
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called CLAAS that closes a small pouch in the heart (left atrial appendage) to prevent strokes in people with atrial fibrillation. About 300 adults at high risk of stroke will get the device under conscious sedation (awake but relaxed). The goal is to see if the device is safe and works well, potentially allowing patients to stop long-term blood thinners.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.